Search:   [Advanced]

Search Results

Search for "Cerivastatin" returned 16 results

Showing 1-16 out of 16

DrugBank ID	Name	Formula	Weight
DB00439	Cerivastatin	C26H34FNO5	459.5503
	Cerivastatin Cerivastatin Pathway SMP00111 Cerivastatin, a competitive HMG-CoA reductase inhibitor effective in lowering LDL cholesterol and triglycerides, is used to treat primary ...
DB01241	Gemfibrozil	C15H22O3	250.3334
	... effect Atorvastatin Increased risk of myopathy/rhabdomyolysis Cerivastatin Increased risk of myopathy/rhabdomyolysis Dicumarol Gemfibrozil increases the anticoagulant effect Fluvastatin ...
DB01039	Fenofibrate	C20H21ClO4	360.8310
	... effect Atorvastatin Increased risk of myopathy/rhabdomyolysis Cerivastatin Increased risk of myopathy/rhabdomyolysis Dicumarol The fibrate increases the anticoagulant effect Fluvastatin ...
DB01394	Colchicine	C22H25NO6	399.4370
	... Increased risk of rhabdomyolysis with this combination Cerivastatin Increased risk of rhabdomyolysis with this combination Clarithromycin Severe colchicine toxicity can occur Cyclosporine ...
DB00559	Bosentan	C27H29N5O6S	551.6140
	... effect Atorvastatin Bosentan could decrease atorvastatin effect Cerivastatin Bosentan could decrease the statin effect Cyclosporine Cyclosporine increases the effect and toxicity of bosentan ...
DB00343	Diltiazem	C22H26N2O4S	414.5180
	... buspirone Carbamazepine Increases the effect of carbamazepine Cerivastatin Increases the effect and toxicity of the statin Cilostazol Increases the effect of cilostazol Cisapride Increases the ...
DB00619	Imatinib	C29H31N7O	493.6027
	... Carbamazepine Carbamazepine decreases levels of imatinib Cerivastatin Imatinib increases the effect and toxicity of statin Clarithromycin The macrolide increases levels of imatinib ...
DB01149	Nefazodone	C25H32ClN5O2	470.0070
	... Carbamazepine Nefazodone increases the effect of carbamazepine Cerivastatin Nefazodone increases the effect and toxicity of the statin drug Cilostazol Nefazodone increases the effect of ...
DB00615	Rifabutin	C46H62N4O11	847.0047
	... levels Buspirone Rifabutin decreases the effect of buspirone Cerivastatin The rifamycin decreases the effect of the statin drug Clarithromycin The rifamycin decreases the effect of the ...
DB01211	Clarithromycin	C38H69NO13	747.9534
	... The macrolide increases the effect of carbamazepine Cerivastatin The macrolide possibly increases the statin toxicity Cisapride Increased risk of cardiotoxicity and arrhythmias Citalopram ...
DB01369	Quinupristin	C87H117N13O19S2	1713.0660
	... This combination presents an increased risk of toxicity Cerivastatin This combination presents an increased risk of toxicity Cisapride This combination presents an increased risk of toxicity ...
DB01026	Ketoconazole	C26H28Cl2N4O4	531.4310
	... The imidazole increases the effect of carbamazepine Cerivastatin Increased risk of myopathy/rhabdomyolysis Chlordiazepoxide The imidazole increases the effect of the benzodiazepine Ciclesonide ...
DB00091	Cyclosporine	C62H111N11O12	1202.6112
	... Cyclosporine increases the effect and toxicity of caspofungin Cerivastatin Possible myopathy and rhabdomyolysis Chloramphenicol Chloramphenicol increases the effect of cyclosporine Chloroquine ...
DB00199	Erythromycin	C37H67NO13	733.9268
	... The macrolide increases the effect of carbamazepine Cerivastatin The macrolide possibly increases the statin toxicity Cilostazol Erythromycin increases the effect of cilostazol Cinacalcet This ...
DB01045	Rifampin	C43H58N4O12	822.9402
	... of caspofungin Celecoxib Decreased levels/effect of the NSAID Cerivastatin The rifamycin decreases the effect of the statin drug Chloramphenicol Rifampin decreases the effect of ...
DB01167	Itraconazole	C35H38Cl2N8O4	705.6330
	... Celiprolol Itaconazole increases levels/effect of celiprolol Cerivastatin Increased risk of myopathy/rhabdomyolysis Chlordiazepoxide The imidazole increases the effect of the benzodiazepine ...

Showing 1-16 out of 16

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.